Financial News
AI-generated market updates and breaking coverage across our tracked tickers.
Lead Story
Johnson & Johnson (JNJ) Market Update: Pre-Market Analysis Following Auris Ruling and Promising Colorectal Cancer Data
Johnson & Johnson (JNJ) sees modest pre-market gains amid mixed news, including a court-ordered recalculation of damages in the Auris Health case and positive clinical trial results. Our analysis covers the key developments and investment considerations for JNJ.
2m readJan 14
Jan 13
Jan 13
Johnson & Johnson (JNJ) Market Update: Pre-Market Analysis and Investment Strategy
2mJNJ• Bearish
Jan 11
Jan 11
Eli Lilly (LLY) Market Update: Zepbound's Promising Clinical Data and a Hold Rating
2mLLY• Bearish
Jan 9
Jan 9
Eli Lilly (LLY) Market Update: Navigating Weight Loss Hype and Oncology Developments
2mLLY• Bearish
Jan 8
Jan 8
MRK Market Update: Analyzing Merck's Closing Performance and Future Outlook
2mMRK• Bullish